Expanded harm reduction provision achieves impressive reductions in HCV incidence among PWID in Scotland
Emergent HCV epidemic among young, non-urban people who inject drugs in the United States
Risk of invasive pneumococcal disease remains high for people living with HIV
Couples-based intervention has impact on HCV incidence and risky sexual behaviour among drug-involved couples in Kazakhstan
Harm reduction prevents HIV, national evidence from Ukraine and Greece shows
Interferon-free hepatitis C treatment works for people on methadone or buprenorphine
Harm reduction funding meeting only 7% of global need
Recession and income inequality have fuelled HIV infections in European drug users
